Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 6022

Sana suspends work on allogeneic CAR-T; Biokin eyes $387M raise in Hong Kong

$
0
0
Plus, news about Codexis, Gilead, nChroma Bio, Bavarian Nordic, UroGen, Agenus, Accipiter Biosciences and Immunocore: ✂️ Sana trims cell therapy pipeline: The Seattle-based biotech is

Viewing all articles
Browse latest Browse all 6022

Trending Articles